Alessio Crippa

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: BIOSTATISTICS. 2023;25(1):220-236

Flexible evaluation of surrogacy in platform studies

Sachs MC; Gabriel EE; Crippa A; Daniels MJ
Article: BJU INTERNATIONAL. 2023;132(6):696-704

Transperineal template saturation and conventional biopsy for stage prediction in prostate cancer

Lehner F; Crippa A; Sigg S; Eberli D; Mortezavi A
Journal article: ANNALS OF ONCOLOGY. 2023;34:s1327

Androgen receptor pathway inhibitors or taxanes for patients with metastatic castration-resistant prostate cancer: A direct comparison in ProBio, a randomized, outcome-adaptive, biomarker-driven platform trial

Gronberg H; Lindberg J; De laere B; Crippa A; Discacciati A; Karlsson CT; Ullen A; Janes E; Mortezavi A; Ost P; Enblad G; Oldenburg J; Sandzen J; Pettersson L; Vigmostad MN; Hjalm-Eriksson ME; Olsson M; Schatteman P; Ghysel C; Eklund M
Article: LANCET DIGITAL HEALTH. 2023;5(10):e703-e711

Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study

Dembrower K; Crippa A; Colon E; Eklund M
Article: BRITISH JOURNAL OF CANCER. 2023;129(1):61-71

Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women

Hammarstroem M; Gabrielson M; Crippa A; Discacciati A; Eklund M; Lundholm C; Baecklund M; Wengstroem Y; Borgquist S; Bergqvist J; Eriksson M; Tapia J; Czene K; Hall P
Journal article: CRITICAL CARE EXPLORATIONS. 2023;5(6):e0930

Trend in Clinical Trial Participation During COVID-19: A Secondary Analysis of the I-SPY COVID Clinical Trial.

Yang P; Dickert NW; Haczku A; Spainhour C; Auld SC
Article: ECLINICALMEDICINE. 2023;58:101889

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial.

I-SPY COVID Consortium
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e997

PD38-11 THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP

Micoli C; Crippa A; Discacciati A; Palsdottir T; Vigneswaran H; Aly M; Adolfsson J; Lindberg J; Wiklund P; Thompson J; Brandberg Y; Clements M; Egevad L; Grönberg H; Nordström T; Eklund M
Article: JOURNAL OF CLINICAL PSYCHIATRY. 2023;84(2):22r14490

It ConTparat1v ruecfs�of l i n ipsychotics on eiglt am anρd' Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis

Sabe M; Pallis K; Solmi M; Crippa A; Sentissi O; Kaiser S
Journal article: EUROPEAN UROLOGY. 2023;83:s1266-s1267

The Stockholm3 prostate cancer screening trial (STHLM3): An interim analysis of mortality results after 6.5 years of follow-up

Micoli C; Crippa A; Discacciati A; Vigneswaran H; Palsdottir T; Clements M; Aly M; Adolfsson J; Fredrik W; Wiklund P; James T; Lindberg J; Gronberg H; Egevad L; Nordstrom T; Eklund M
Article: BMJ OPEN. 2022;12(6):e060664

I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations

Files DC; Matthay MA; Calfee CS; Aggarwal NR; Asare AL; Beitler JR; Berger PA; Burnham EL; Cimino G; Coleman MH; Crippa A; Discacciati A; Gandotra S; Gibbs KW; Henderson PT; Ittner CAG; Jauregui A; Khan KT; Koff JL; Lang J; LaRose M; Levitt J; Lu R; McKeehan JD; Meyer NJ; Russell DW; Thomas KW; Eklund M; Esserman LJ; Liu KD
Article: JAMA NETWORK OPEN. 2022;5(4):e228959

Association of Open vs Robot-Assisted Radical Cystectomy With Mortality and Perioperative Outcomes Among Patients With Bladder Cancer in Sweden

Mortezavi A; Crippa A; Kotopouli MI; Akre O; Wiklund P; Hosseini A
Journal article: INVESTIGATIVE UROLOGY. 2021;206(Supplement 3):e565-e566

MP32-04 PROGRESSION ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER IN BLACK MEN: A SYSTEMATIC REVIEW AND META-ANALYSIS

Vigneswaran H; Mittelstaedt L; Crippa A; Eklund M; Vidal A; Freedland S; Abern M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(17):1899-1908

Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial

Eriksson M; Eklund M; Borgquist S; Hellgren R; Margolin S; Thoren L; Rosendahl A; Lang K; Tapia J; Backlund M; Discacciati A; Crippa A; Gabrielson M; Hammarstrom M; Wengstrom Y; Czene K; Hall AP
Article: BJU INTERNATIONAL. 2021;127(5):585-595

Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group

Mortezavi A; Crippa A; Edeling S; Pokupic S; Dell'Oglio P; Montorsi F; D'Hondt F; Mottrie A; Decaestecker K; Wijburg CJ; Collins J; Kelly JD; Tan WS; Sridhar A; John H; Canda AE; Schwentner C; Ronmark EP; Wiklund P; Hosseini A
Article: WORLD JOURNAL OF UROLOGY. 2021;39(4):1153-1159

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

Lantz A; Haug ES; Picker W; Crippa A; Jaderling F; Mortezavi A; Nordstrom T
Article: CANCERS. 2021;13(7):1588

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer

De Laere B; Crippa A; Mortezavi A; Ghysel C; Rajan P; Eklund M; Wyatt A; Dirix L; Ost P; Gronberg H; Lindberg J
Article: TRIALS. 2020;21(1):579

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Crippa A; De Laere B; Discacciati A; Larsson B; Connor JT; Gabriel EE; Thellenberg C; Janes E; Enblad G; Ullen A; Hjalm-Eriksson M; Oldenburg J; Ost P; Lindberg J; Eklund M; Gronberg H
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2020;177(4):342-353

Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia

Leucht S; Crippa A; Siafis S; Patel MX; Orsini N; Davis JM
Article: BMJ OPEN. 2019;9(12):e033650

Effect of tobacco control policies on the Swedish smoking quitline using intervention time-series analysis

Zhou X; Crippa A; Danielsson A-K; Galanti MR; Orsini N
Journal article: ANNALS OF ONCOLOGY. 2019;30:v354

896TiP ProBio: An outcome-adaptive, multi-arm, open-label, multiple assignment randomised controlled biomarker-driven trial in patients with metastatic castration-resistant prostate cancer

Lindberg J; De Laere B; Crippa A; Eklund M; Grönberg H
Journal article: ANNALS OF ONCOLOGY. 2019;30:v30-v31

106P Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer

De Laere B; Crippa A; Ghysel C; Ost P; Rajan P; Eklund M; Dirix L; Grönberg H; Lindberg J
Article: STATISTICAL METHODS IN MEDICAL RESEARCH. 2019;28(5):1579-1596

One-stage dose-response meta-analysis for aggregated data

Crippa A; Discacciati A; Bottai M; Spiegelman D; Orsini N
Journal article: INTERNATIONAL JOURNAL OF STATISTICS IN MEDICAL RESEARCH. 2018;7(2):25-32

A Pointwise Approach to Dose-Response Meta-Analysis of Aggregated Data

Crippa A; Thomas I; Orsini N
Article: EUROPEAN JOURNAL OF NUTRITION. 2018;57(2):689-701

Red and processed meat consumption and risk of bladder cancer: a dose-response meta-analysis of epidemiological studies

Crippa A; Larsson SC; Discacciati A; Wolk A; Orsini N
Article: RESEARCH SYNTHESIS METHODS. 2017;8(2):149-160

Goodness of fit tools for dose-response meta-analysis of binary outcomes

Discacciati A; Crippa A; Orsini N
Article: DIABETOLOGIA. 2016;59(12):2527-2545

Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies

Smith AD; Crippa A; Woodcock J; Brage S
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2016;5(10):e004210

Meta-Analysis of Potassium Intake and the Risk of Stroke

Vinceti M; Filippini T; Crippa A; de Sesmaisons A; Wise LA; Orsini N
Article: STATISTICS IN MEDICINE. 2016;35(21):3661-3675

A new measure of between-studies heterogeneity in meta-analysis

Crippa A; Khudyakov P; Wang M; Orsini N; Spiegelman D
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2016;16:91

Dose-response meta-analysis of differences in means

Crippa A; Orsini N
Journal article: CIRCULATION. 2016;133(suppl_1)

Abstract P004: Estimating the Mortality Benefits of Ideal Cardiovascular Health: A Dose-response Meta-analysis

Aneni EC; Crippa A; Younus A; Osondu CU; Veledar E; Nasir K
Article: JOURNAL OF STATISTICAL SOFTWARE. 2016;72(CS1):1-15

Multivariate Dose-Response Meta-Analysis: The dosresmeta R Package

Crippa A; Orsini N
Article: NUTRIENTS. 2015;7(9):7749-7763

Milk Consumption and Mortality from All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis

Larsson SC; Crippa A; Orsini N; Wolk A; Michaelsson K
Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(5):446

Fish consumption and risk of rheumatoid arthritis: a dose-response meta-analysis

Di Giuseppe D; Crippa A; Orsini N; Wolk A
Visa fler

Alla övriga publikationer

Review: BRITISH JOURNAL OF SPORTS MEDICINE. 2023;57(15):979-989

Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies

Garcia L; Pearce M; Abbas A; Mok A; Strain T; Ali S; Crippa A; Dempsey PC; Golubic R; Kelly P; Laird Y; McNamara E; Moore S; de Sa TH; Smith AD; Wijndaele K; Woodcock J; Brage S
Conference publication: JOURNAL OF UROLOGY. 2023;209:E997-E998

THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP

Micoli C; Crippa A; Discacciati A; Palsdottir T; Vigneswaran H; Aly M; Adolfsson J; Lindberg J; Wiklund P; Thompson J; Brandberg Y; Clements M; Egevad L; Gronberg H; Nordstrom T; Eklund M
Editorial comment: EUROPEAN UROLOGY FOCUS. 2022;8(6):1617-1621

Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate Cancer

De laere B; Crippa A; Discacciati A; Larsson B; Oldenburg J; Mortezavi A; Ost P; Eklund M; Lindberg J; Gronberg H
Preprint: 2022

Flexible evaluation of surrogacy in Bayesian adaptive platform studies

Sachs MC; Gabriel EE; Crippa A; Daniels MJ
Preprint: MEDRXIV. 2022

The I-SPY COVID Adaptive Platform Trial for COVID-19 Acute Respiratory Failure: Rationale, Design and Operations

Files DC; Matthay MA; Calfee CS; Aggarwal N; Asare AL; Beitler JR; Berger PA; Burnham EL; Cimino G; Coleman MH; Crippa A; Discacciati A; Gandotra S; Gibbs KW; Henderson PT; Ittner CAG; Jauregui A; Khan KT; Koff JL; Lang J; LaRose M; Levitt J; Lu R; McKeehan JD; Meyer NJ; Russell DW; Thomas KW; Eklund M; Esserman LJ; Liu KD
Conference publication: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2022;205:a5284

The I-SPY COVID Trial: First Results from an Adaptive Platform Phase 2 Trial for Severe COVID-19

Calfee CS; Eklund M; Albertson TE; Auld S; Beitler JR; Berger PA; Burnham EL; Cobb NK; Crippa A; Daniel BM; Discacciati A; Files DC; Friedman EB; Gandotra S; Gong MN; Khan KT; Koff JL; Kumar SI; Lang JE; Lu R; Martin TR; Matthay MA; Meyer NJ; Moskowitz A; Obermiller TF; Robinson PA; Russell D; Thomas KW; Wong S; Wurfel MM; Wunderink RG; Yen YF; Youssef FA; Esserman LJ; Liu KD
Preprint: MEDRXIV. 2022

Non-occupational physical activity and risk of 22 cardiovascular disease, cancer, and mortality outcomes: a dose-response meta-analysis of large prospective studies

Garcia L; Pearce M; Abbas A; Mok A; Strain T; Ali S; Crippa A; Dempsey PC; Golubic R; Kelly P; Laird Y; McNamara E; Moore S; de TH; Smith AD; Wijndaele K; Woodcock J; Brage S
Review: PROSTATE CANCER AND PROSTATIC DISEASES. 2022;25(2):165-173

Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis

Vigneswaran HT; Mittelstaedt L; Crippa A; Eklund M; Vidal A; Freedland SJ; Abern MR
Letter: NATURE MEDICINE. 2022;28(1):9-11

Clinical trial design during and beyond the pandemic: the I-SPY COVID trial

Calfee CS; Liu KD; Asare AL; Beitler JR; Berger PAIII; Coleman MH; Crippa A; Discacciati A; Eklund M; Files DC; Gandotra S; Gibbs KW; Henderson P; Levitt JE; Lu R; Matthay MA; Meyer NJ; Russell DW; Thomas KW; Esserman LJ; Mittel AM; Dzierba AL; Madahar P; Serra AL; Rosen A; Garcia I; Muir J; Schicchi J; Darmanian A; Wahab R; Gosek K; Auld SC; Adelman MW; Nugent KL; Harris GH; Creel-Bulos C; Yang P; Detelich JF; Spainhour C; Cobb NK; Sonti R; Orr LA; Robinson PA; Sarafian F; Martinez E; Jones P; Nguyen J; Obermiller TF; Weiler-Lisowski B; Kufa L; Saba PL; Wyatt J; Youssef FA; Tanios M; Blevins D; Macias LR; Suarez AE; Reyes MB; Jung M; Melendrez M; Rosario-Remigio L; Su H; Friedman EB; Angelucci CM; Chaparro-Rojas F; Sternlieb MP; Sutter JB; Whealon S; Nair R; Lopez B; Amosu O; Tzehaie H; Wunderink RG; Patel C; Simonson A; Dodin J; Oliver T; Lupu RA; Meyers M; Albertson TE; Haczku A; Hardy E; Morrissey BM; Juarez MM; Pearson SJ; Lee RA; Amin AN; Jauregui A; Fields S; Ng D; Daniel BM; Yee K; Jones C; Burnham EL; McKeehan JD; Ittner CAG; Reilly JP; Mangalmurti NS; Rodrigues LG; Weisman AR; Khan KT; Wong SF; Yen AF; Peterfreund G; Kumar SI; Marshall PS; Huerta LE; Lindgren B; Lee JS; Barker AD; Lang JE; LaRose M; Landreth L; Parks L; Barot HV; Koff JL; Kazianis J; Boerger LL
Review: NPJ SCHIZOPHRENIA. 2021;7(1):43

Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials

Sabe M; Zhao N; Crippa A; Kaiser S
Review: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2021;24(8):601-614

Intranasal oxytocin for Negative Symptoms of Schizophrenia: Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of Randomized Controlled Trials

Sabe M; Zhao N; Crippa A; Strauss GP; Kaiser S
Review: BRITISH JOURNAL OF SPORTS MEDICINE. 2020;54(20):1195-1201

Association of high amounts of physical activity with mortality risk: a systematic review and meta-analysis

Blond K; Brinklov CF; Ried-Larsen M; Crippa A; Grontved A
Preprint: RESEARCH SQUARE. 2020

The ProBio Trial: Molecular Biomarkers for Advancing Personalized Treatment Decision in Patients with Metastatic Castration-Resistant Prostate Cancer

Crippa A; De Laere B; Discacciati A; Larsson B; Connor JT; Gabriel EE; Thellenberg C; Jänes E; Enblad G; Ullen A; Hjälm-Eriksson M; Oldenburg J; Ost P; Lindberg J; Eklund M; Grönberg H
Preprint: RESEARCH SQUARE. 2020

The ProBio Trial: Molecular Biomarkers for Advancing Personalized Treatment Decision in Patients with Metastatic Castration-Resistant Prostate Cancer

Crippa A; De Laere B; Discacciati A; Larsson B; Connor JT; Gabriel EE; Thellenberg C; Jänes E; Enblad G; Ullen A; Hjälm-Eriksson M; Oldenburg J; Ost P; Lindberg J; Eklund M; Grönberg H
Review: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2019;20(5):569-582.e7

Nutritional Status, Body Mass Index, and the Risk of Falls in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis

Trevisan C; Crippa A; Ek S; Welmer A-K; Sergi G; Maggi S; Manzato E; Bea JW; Cauley JA; Decullier E; Hirani V; LaMonte MJ; Lewis CE; Schott A-M; Orsini N; Rizzuto D
Review: ENVIRONMENTAL HEALTH PERSPECTIVES. 2019;127(4):46002

Association between Outdoor Air Pollution and Childhood Leukemia: A Systematic Review and Dose Response Meta-Analysis

Filippini T; Hatch EE; Rothman KJ; Heck JE; Park AS; Crippa A; Orsini N; Vinceti M
Conference publication: ANNALS OF ONCOLOGY. 2019;30:354

ProBio: An outcome-adaptive, multi-arm, open-label, multiple assignment randomised controlled biomarker-driven trial in patients with metastatic castration-resistant prostate cancer

Lindberg J; De Laere B; Crippa A; Eklund M; Gronberg H
Conference publication: ANNALS OF ONCOLOGY. 2019;30

Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer

De Laere B; Crippa A; Ghysel C; Ost P; Rajan P; Eklund M; Dirix L; Gronberg H; Lindberg J
Review: EUROPEAN JOURNAL OF CANCER. 2018;104:117-126

Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis

Lugo A; Peveri G; Bosetti C; Bagnardi V; Crippa A; Orsini N; Rota M; Gallus S
Conference publication: SCHIZOPHRENIA BULLETIN. 2018;44:S94

DOSE-RESPONSE META-ANALYSIS TO IDENTIFY THE OPTIMUM AND EQUIVALENT DOSES OF ANTIPSYCHOTIC DRUGS FOR SCHIZOPHRENIA

Leucht S; Crippa A; Orsini N; Davis J
Thesis / dissertation: 2018

Novel methods for dose-response meta-analysis

Crippa, Alessio
Conference publication: JOURNAL OF PHYSICAL ACTIVITY & HEALTH. 2018;15(10):S36

Non-occupational physical activity and risk of cardiovascular disease, cancer, and mortality: a dose-response meta-analysis of prospective studies

Brage S; Abbas A; Mok A; Garcia L; McNamara E; Crippa A; Sa T; Smith A; Kim D; Im J; Olayinka O; Golubic R; Pearce M; Tainio M; Wijndaele K; Edwards P; Woodcock J
Review: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2017;6(12):e006904

Estimates of Mortality Benefit From Ideal Cardiovascular Health Metrics: A Dose Response Meta-Analysis

Aneni EC; Crippa A; Osondu CU; Valero-Elizondo J; Younus A; Nasir K; Veledar E
Conference publication: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2017;27:ckx187.235

Avoid exclusion of studies in synthesis of dose-response data using a novel one-stage approach

Crippa A; Orsini N
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;222:737

Letter to Editor: "Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: A meta-analysis"

Veledar E; Crippa A; Osondu CU; Younus A; Nasir K
Letter: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2016;43(1):166-167

Letter: coffee consumption and gallstone disease - a cautionary note on the assignment of exposure values in dose-response meta-analyses

Crippa A; Discacciati A; Orsini N; Oskarsson V
Review: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2014;180(8):763-775

Coffee Consumption and Mortality From All Causes, Cardiovascular Disease, and Cancer: A Dose-Response Meta-Analysis

Crippa A; Discacciati A; Larsson SC; Wolk A; Orsini N
Visa fler

Forskningsbidrag

ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer

Swedish Research Council

1 January 2022 - 31 December 2025

Anställningar

Senior Forskningsspecialist, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2022-

Examina och utbildning

Medicine Doktorsexamen, Institutionen för global folkhälsa, Karolinska Institutet, 2018

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI